| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 1.119 | 2.805 | 13.461 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 1.119 | 2.805 | 13.463 |
| Total Expenses - EUR | - | - | - | - | 840 | 4.870 | 7.739 | 12.897 | 13.071 | 6.265 |
| Gross Profit/Loss - EUR | - | - | - | - | -840 | -4.870 | -7.739 | -11.778 | -10.266 | 7.198 |
| Net Profit/Loss - EUR | - | - | - | - | -840 | -4.870 | -7.739 | -11.812 | -10.266 | 6.046 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dahamsha Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 74.052 | 4.356 | 6.108 | 6.127 | 13.240 | 12.317 |
| Current Assets | - | - | - | - | 30.356 | 934 | 2.709 | 5.309 | 10.381 | 98.052 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 1.115 | 913 | 2.692 | 5.047 | 8.291 | 89.738 |
| Cash | - | - | - | - | 29.241 | 21 | 17 | 262 | 2.089 | 8.314 |
| Shareholders Funds | - | - | - | - | -797 | -3.875 | -11.529 | -23.376 | -33.531 | -27.297 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 105.205 | 9.165 | 20.345 | 34.812 | 57.152 | 137.666 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Dahamsha Medical S.r.l.